Global Hodgkins Lymphoma Drugs Market 2019-2023
| Published: Feb 2019 | Pages: 113 | SKU: IRTNTR30809 |
Below are some of the key findings from the Hodgkin’s lymphoma drugs market research report
See the complete table of contents and list of exhibits, as well as selected illustrations and example pages from this report.
Global Hodgkin’s lymphoma drugs industry overview
The continuous advances in the understanding of fundamental biology of Hodgkin’s lymphoma is one of the key factors expected to trigger the market’s growth in the forthcoming years. There have been several types of research conducted for meeting the high unmet need for novel and innovative alternative treatment approaches for treating this condition. Companies are developing drugs to treat Hodgkin’s lymphoma effectively. Additionally, researchers are also focusing on understanding the role of oncogenic viruses, anti-apoptosis mechanisms of Hodgkin’s and Reed Sternberg cells, and molecular reasons for the characteristic phenotype of the disease. This will drive Hodgkin’s lymphoma drugs market growth at a CAGR of close to 16% during the forecast period.
Given the rising instances of the disease, many companies are focusing on investing in the research and development of novel drugs for the treatment of Hodgkin’s lymphoma. Many market players are conducting research focusing on the development of new therapies for improving long-term remission rates. Additionally, companies are also evaluating premium-priced drugs in the pipeline. The acceptance of some costly or high-prices drugs will further boost the Hodgkin’s lymphoma drugs market growth in the forthcoming years.
Top Hodgkin’s lymphoma drugs companies covered in this market research report
The Hodgkin’s lymphoma drugs market is moderately concentrated with companies focusing on investing in the R&D of novel drugs to strengthen the quality of drugs. By offering a complete analysis of the market’s competitive landscape and with information on the products offered by companies, this Hodgkin’s lymphoma drugs industry analysis report will aid clients to identify new growth opportunities and design new growth strategies.
The report offers a complete analysis of various companies including:
- Bristol-Myers Squibb Company
- Merck & Co., Inc.
- ONO PHARMACEUTICAL CO., LTD.
- Pfizer Inc.
- Seattle Genetics, Inc.
Hodgkin’s lymphoma drugs market segmentation based on geographic regions
- Asia
- Europe
- North America
- ROW
With a complete study of the growth opportunities for companies, it has been estimated that North America will account for the largest Hodgkin’s lymphoma drugs market share throughout the forecast period. The region will continue its market dominance because of the growing incidences of Hodgkin’s lymphoma coupled with the presence of reimbursement schemes.
Hodgkin’s lymphoma drugs market segmentation based on the type
- Targeted therapy
- Chemotherapy
The targeted therapy segment will account for the highest Hodgkin’s lymphoma drugs market share during the forecast period. The segment will account for the highest growth because of the approvals of new drug ADCETRIS and KEYTRUDA. The report provides an accurate prediction of the contribution of the various drug type segments to the growth of the Hodgkin’s lymphoma drugs market size.
Key highlights of the global Hodgkin’s lymphoma drugs market for the forecast years 2019-2023:
- CAGR of the market during the forecast period 2019-2023
- Detailed information on factors that will accelerate the growth of the Hodgkin’s lymphoma drugs market during the next five years
- Precise estimation of the global Hodgkin’s lymphoma drugs market size and its contribution to the parent market
- Accurate predictions on upcoming trends and changes in consumer behavior
- The growth of the Hodgkin’s lymphoma drugs industry across Asia, Europe, North America, and ROW
- A thorough analysis of the market’s competitive landscape and detailed information on several vendors
- Comprehensive details on the factors that will challenge the growth of Hodgkin’s lymphoma drugs companies
We can help! Our analysts can customize this market research report to meet your requirements. Get in touch
PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
- 2.1 Preface
- 2.2 Preface
- 2.3 Currency conversion rates for US$
PART 03: MARKET LANDSCAPE
- Market ecosystem
- Market characteristics
- Market segmentation analysis
PART 04: PIPELINE ANALYSIS
PART 05: MARKET SIZING
- Market definition
- Market sizing 2018
- Market size and forecast 2018-2023
PART 06: FIVE FORCES ANALYSIS
- Bargaining power of buyers
- Bargaining power of suppliers
- Threat of new entrants
- Threat of substitutes
- Threat of rivalry
- Market condition
PART 07: MARKET SEGMENTATION BY TYPE
- Market segmentation by type
- Comparison by type
- Targeted therapy - Market size and forecast 2018-2023
- Chemotherapy - Market size and forecast 2018-2023
- Market opportunity by type
PART 08: CUSTOMER LANDSCAPE
PART 09: GEOGRAPHIC LANDSCAPE
- Geographic segmentation
- Geographic comparison
- North America - Market size and forecast 2018-2023
- Europe - Market size and forecast 2018-2023
- Asia - Market size and forecast 2018-2023
- ROW - Market size and forecast 2018-2023
- Key leading countries
- Market opportunity
PART 10: DECISION FRAMEWORK
PART 11: DRIVERS AND CHALLENGES
- Market drivers
- Market challenges
PART 12: MARKET TRENDS
- Market trends
PART 13: VENDOR LANDSCAPE
- Overview
- Landscape disruption
PART 14: VENDOR ANALYSIS
- Vendors covered
- Vendor classification
- Market positioning of vendors
- Bristol-Myers Squibb Company
- Merck & Co., Inc.
- ONO PHARMACEUTICAL CO., LTD.
- Pfizer Inc.
- Seattle Genetics, Inc.
PART 15: APPENDIX
- Research methodology
- List of abbreviations
PART 16: EXPLORE TECHNAVIO
Research Framework
Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.
INFORMATION SOURCES
Primary sources
- Manufacturers and suppliers
- Channel partners
- Industry experts
- Strategic decision makers
Secondary sources
- Industry journals and periodicals
- Government data
- Financial reports of key industry players
- Historical data
- Press releases
DATA ANALYSIS
Data Synthesis
- Collation of data
- Estimation of key figures
- Analysis of derived insights
Data Validation
- Triangulation with data models
- Reference against proprietary databases
- Corroboration with industry experts
REPORT WRITING
Qualitative
- Market drivers
- Market challenges
- Market trends
- Five forces analysis
Quantitative
- Market size and forecast
- Market segmentation
- Geographical insights
- Competitive landscape
PURCHASE FULL REPORT OF
market
Key Questions Answered
- What are the key global market and the regional market share?
- What are the revenue-generating key market segments?
- What are the key factors driving and challenging this market’s growth?
- Who are the key market vendors and their growth strategies?
- What are the latest trends influencing the growth of this market?
- What are the variables influencing the market growth in the primary regions?
- What are the factors influencing the growth of the parent market?
Why should you prefer Technavio's market insights report?
- Off-the-shelf research reports
- Reports can be tailored to meet the customer's needs
- Trusted by more than 100 fortune 500 organizations
- Information about the market's key drivers, trends, and challenges
- Parent market analysis
- Every week, 50,000 people visit our subscription platform
- Detailed vendors report with competitive landscape
- Covid-19 impact and recovery analysis
- Data on revenue-generating market segments
- Details on the market shares of various regions
- Five-force market analysis